For general media inquiries, please contact mediainquiries@jenner.com.
News
Jenner & Block Secures Trial Victory for Chance the Rapper
News
Recognition
Jenner & Block Named Law Firm of the Year, Earned Additional Honors Across Categories by The American Lawyer 2025 Industry Awards
Recognition
Recognition
Chicago Bar Association Names Jenner & Block Law Firm of the Year
Recognition
All News and Insights
News
Jenner & Block is pleased to announce that Michael J. Vernick has joined as a Partner in its Washington, DC, office.
Jenner & Block has launched its Post-Chevron Task Force to support clients across industries in navigating the June 2024 US Supreme Court decisions in Loper Bright, Relentless, Corner Post, and Jarkesy. The decisions reversed the Chevron deference, a 40-year precedent that established that courts should defer to federal agencies’ interpretations of ambiguous statutes, injecting significant uncertainty into the regulatory landscape.
Firm Client Theratechnologies Establishes New At-The-Market Facility
On July 23, biopharmaceutical company Theratechnologies Inc. established an at-the-market equity program allowing it to issue and sell up to $50 million of its common shares to the public at the prevailing market price. Led by Partner Martin C. Glass, the team included Partners Geoffrey M. Davis and Louis E. Fogel and Associate Kristen M. Iglesias.
Recognitions
Jenner & Block Partners Gianni Servodidio and Rémi Jaffré were honored as The American Lawyer’s Litigators of the Week for securing a multi-court victory on behalf of MSN Pharmaceuticals, clearing the path for the launch of the first generic version of Entresto, a life-saving heart failure medication.
Jenner & Block Named to The American Lawyer’s A-List
Jenner & Block has been named to The American Lawyer’s 2024 A-List, an annual list highlighting the 20 most well-rounded firms according to both financial and cultural criteria.
Publications
Recent Rulings Highlight Risk to Japanese Drugmakers in Settling Pharmaceutical Litigations
In FTC v. Actavis, Inc., 570 U.S. 136 (2013), the US Supreme Court addressed the legality of “reverse payment” settlements in pharmaceutical patent litigation. A reverse payment occurs when a brand-name drug manufacturer pays a generic drug manufacturer to settle patent litigation and delay the generic’s market entry, essentially paying the potential competitor not to compete. Since Actavis, pharmaceutical companies’ settlements have become more complex, often finding ways to provide value to ge
In September, amid the divisive runup to the election, Senate Democrats and Republicans found something they could agree on: the CEO of Steward Health Care should be referred for criminal prosecution for refusing to appear at a hearing. The Senate’s unanimous vote marked the latest escalation in the legislative branch’s use of its coercive powers against private individuals. Partner Emily Loeb and Associates Sam Ungar and Michael Brady discuss why this vote may be a harbinger of even more aggres
Events
“2023 CPR Annual Meeting,” International Institute for Conflict Prevention & Resolution
Three Jenner & Block partners will share their insights at the annual meeting of International Institute for Conflict Prevention & Resolution. The event offers a deep dive into alternative dispute resolution tools, techniques, and best practices. On March 1, Partner Todd C. Toral will moderate, and Partner Shoba Pillay will speak at a panel called “Blame the Victim?” This discussion will explore the implications of a cybersecurity incident, including how to meaningfully prepare for litigation, m